Hubei Biocause Pharmaceutical Cash Flow Quality Index
Hubei Biocause Pharmaceutical cash flow quality index. Hubei Biocause Pharmaceutical (000627) has a Cash Flow Quality Index of 135.70x as of March 2023. Operating cash flow of CN¥6.13 Billion exceeds net income of CN¥45.21 Million, indicating high earnings quality where cash backs reported profits. See Hubei Biocause Pharmaceutical leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Hubei Biocause Pharmaceutical (2001–2022)
Cash flow quality index of Hubei Biocause Pharmaceutical from 2001 to 2022. Historical Cash Flow Quality Index for Hubei Biocause Pharmaceutical across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore debt repayment capacity of Hubei Biocause Pharmaceutical to assess how comfortably operating cash covers total debt obligations.
Hubei Biocause Pharmaceutical Cash Flow Quality Index by Year (2001–2022)
Hubei Biocause Pharmaceutical cash flow quality index by year from 2001 to 2022. Year-by-year earnings quality comparison for Hubei Biocause Pharmaceutical. For the full cash flow conversion analysis, see 000627 operating cash flow.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 27.46x | CN¥7.52 Billion | CN¥274.05 Million | ▲ +209.7% |
| 2021 | 8.86x | CN¥4.17 Billion | CN¥470.71 Million | ▼ -76.0% |
| 2020 | 36.91x | CN¥21.42 Billion | CN¥580.29 Million | ▲ +129.2% |
| 2019 | 16.10x | CN¥28.60 Billion | CN¥1.78 Billion | ▲ +42.6% |
| 2018 | 11.29x | CN¥14.98 Billion | CN¥1.33 Billion | ▲ +3370.4% |
| 2017 | 0.33x | CN¥431.58 Million | CN¥1.33 Billion | ▲ +124.7% |
| 2016 | -1.32x | CN¥-2.34 Billion | CN¥1.78 Billion | ▼ -596.8% |
| 2015 | -0.19x | CN¥-46.73 Million | CN¥247.27 Million | ▼ -102.4% |
| 2012 | 7.93x | CN¥93.79 Million | CN¥11.82 Million | ▲ +0.0% |
| 2010 | 7.93x | CN¥224.58 Million | CN¥28.32 Million | ▲ +569.2% |
| 2007 | 1.19x | CN¥118.56 Million | CN¥100.05 Million | ▼ -55.3% |
| 2006 | 2.65x | CN¥128.19 Million | CN¥48.37 Million | ▼ -61.3% |
| 2005 | 6.85x | CN¥48.66 Million | CN¥7.10 Million | ▼ -37.8% |
| 2004 | 11.01x | CN¥56.07 Million | CN¥5.09 Million | ▲ +999.2% |
| 2001 | 1.00x | CN¥37.30 Million | CN¥37.23 Million | — |